Zoll Medical, a healthcare products manufacturer based in Chelmsford, Massachusetts, announced that it had received approval in Japan for its novel intravascular temperature management device. According to a press release by the company, Zoll Medical is the sole manufacturer for this type of device.

With the approval, Zoll states that doctors will be able to use its intravascular technology to control fevers in patients suffering from neurological disorders. While simple, the device is very effective. The device comprises a specialized heating / cooling system and a balloon catheter. Once inserted into a patient’s venous system, the catheter warms or cools a patient’s blood.

As of now, Zoll has a cardiac support pump, a portable diagnostic device and an automated defibrillator available in Japan. The company has also undergone an ownership change in recent years. Last year, Zoll was purchased by Asahi Kasei for $2.2 billion. Sales in Japan will be managed through a subsidiary called Asahi Kasei Zoll Medical.

James Palazzolo is the president of Zoll’s operations in Sunnyvale, California. In prepared remarks, he said, “We are very excited to begin commercialization of IVTM in Japan and to continue to offer innovative technologies and devices for critical care to this high-growth market.” He continued, “We are now preparing for a clinical trial for therapeutic hypothermia following cardiopulmonary resuscitation, a treatment having a Class 1 recommendation from both the American Heart Association (AHA) and the Japan Resuscitation Council (JRC).”

References

www.zoll.com/news-releases